# Ria Health

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/ria-health

- Industry: Healthcare IT
- Headquarters: San Francisco, US
- Website: www.riahealth.com
- Total disclosed funding: $18M
- Latest round: Series B (Mar 6, 2025)
- Investors on record: 4

## About

Founded in 2016, DxRx, Inc. was co-founded by Dr John Mendelson, a medical expert, David Deacon, a venture capitalist, and Bob Nix, a health IT technician, operating as a program facing to the US domestic market to treat people with drinking problem. The program is teamed up by doctors, nurse practitioners, addiction counselors, tech developers, marketers, business leaders, and experienced nonprofit workers. In 2022, the company received USD 2 million from National Institutes of Health (NIH) for Clinical Trial that aimed to assess its medically assisted treatment program’s effectiveness, with the partnership from Stanford University. Since the beginning of 2020, the company's platform Ria Health has seen a fivefold increase in patient enrollment and a tenfold increase in alcohol treatment-seeking adults. Up till 2023, the company has treated over 4,000 people with alcoholism.

The company provides consultancy service, medication, coaching, telemedicine, moderation, and The Sinclair Method treatment (TSM). To be specific, the company prescribes several FDA-approved medications to reduce alcohol cravings, including naltrexone, acamprosate, and gabapentin. Weekly coaching sessions help members learn new coping skills, assess their progress, and troubleshoot recovery challenges are provided as well. The telemedicine service can provide medical counseling, coaching sessions, virtual support groups, and digital progress-tracking tools via mobile app called Ria Health. Moderation service works as an option for people with alcoholism to go back to moderate drinking habit. TSM involves taking the medication naltrexone while continuing to drink, blocking the endorphin rush from alcohol, which is a new approach to avoid over drinking.

The company will utilize USD 18 million raised in 2023 to expand its care delivery service to meet the  AUD treatment demand from health plans, multi-state employers, Taft-Hartley plans, and healthcare providers.

## Funding rounds

- Series B, Mar 6, 2025 — EQT Private Capital Asia, SV Health Investors, SOSV, Peloton Equity
- Series A, Jun 3, 2022, $18M — EQT Private Capital Asia, SV Health Investors, SOSV

## Investors

- EQT Private Capital Asia (https://capitalatlas.ai/funds/eqt-private-capital-asia) — Series A, Series B
- SV Health Investors (https://capitalatlas.ai/funds/sv-health-investors) — Series A, Series B
- SOSV (https://capitalatlas.ai/funds/sosv) — Series A, Series B
- Peloton Equity (https://capitalatlas.ai/funds/peloton-equity) — Series B